Is cetuximab used for colorectal cancer?

Is cetuximab used for colorectal cancer?

Cetuximab, which targets a protein known as EGFR, has already been approved to treat some patients with colorectal cancer. Until this new approval, encorafenib, which targets the BRAF protein, was only approved to treat patients with melanoma whose tumors had BRAF mutations.

What is the CPT code for cetuximab?

HCPCS code J9055 for Injection, cetuximab, 10 mg as maintained by CMS falls under Chemotherapy Drugs.

Is Erbitux a targeted therapy?

Cetuximab (Erbitux)–an emerging targeted therapy for epidermal growth factor receptor-expressing tumours.

Is cetuximab a biologic?

The chimeric IgG1 monoclonal antibody cetuximab (ERBITUX, ImClone Systems Incorporated, New York, NY and Bristol-Myers Squibb Company, Princeton, NJ) was the first biologic directed against EGFR to receive approval by the FDA for use in mCRC.

Is Erbitux chemotherapy?

ERBITUX with a type of chemotherapy called FOLFIRI (irinotecan, fluorouracil, leucovorin) was studied in a clinical trial of 1217 people with EGFR-expressing colorectal cancer that had spread (metastasized) to other parts of the body.

When is Erbitux used?

Cetuximab is used to treat a certain type of cancer of the colon (large intestine) or rectum. This medication is also used to treat head and neck cancer. Cetuximab works by slowing or stopping the growth of cancer cells.

Does Medicare cover Erbitux?

Decision. The Centers for Medicare & Medicaid Services (CMS) will cover the use of oxaliplatin (Eloxatin™), irinotecan (Camptosar®), cetuximab (Erbitux™), or bevacizumab (Avastin™), in clinical trials identified by CMS and sponsored by the National Cancer Institute (NCI).

Is Erbitux a chemo?

What drug class is Erbitux?

Drug type: Cetuximab is an anti-cancer (“anti-neoplastic”) targeted therapy. This medication is classified as a “monoclonal antibody” and “Epidermal Growth Factor Receptor (EGFR) Inhibitor.” (For more detail, see “How this drug works” section below).

What type of anticancer therapy is cetuximab?

Cetuximab is an IgG1 monoclonal antibody to the epidermal growth factor receptor (EGFR) and it exerts clinical activity in mCRC patients who are chemotherapy-resistant[6-8].